|
1
|
Loong HH, Ma BB and Chan AT: Update on the
management and therapeutic monitoring of advanced nasopharyngeal
cancer. Hematol Oncol Clin North Am. 22:1267–1278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan AT, Teo PM and Johnson PJ:
Nasopharyngeal carcinoma. Ann Oncol. 13:1007–1015. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sanguineti G, Geara FB, Garden AS, Tucker
SL, Ang KK, Morrison WH and Peters LJ: Carcinoma of the nasopharynx
treated by radiotherapy alone: Determinants of local and regional
control. Int J Radiat Oncol Biol Phys. 37:985–996. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji JL, Huang XF and Zhu HL: Curcumin and
its formulations: Potential anti-cancer agents. Anticancer Agents
Med Chem. 12:210–218. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rahmani AH, Al Zohairy MA, Aly SM and Khan
MA: Curcumin: A potential candidate in prevention of cancer via
modulation of molecular pathways. Biomed Res Int. 2014:7616082014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
López-Jornet P, Camacho-Alonso F and
Gómez-Garcia F: Effect of curcumin and irradiation in PE/CA-PJ15
oral squamous cell carcinoma. Acta Odontol Scand. 69:269–273. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang YJ, Huang CY, Hung CS, Chen WY and
Wei PL: GRP78 mediates the therapeutic efficacy of curcumin on
colon cancer. Tumour Biol. 36:633–641. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie YQ, Wu XB and Tang SQ: Curcumin
treatment alters ERK-1/2 signaling in vitro and inhibits
nasopharyngeal carcinoma proliferation in mouse xenografts. Int J
Clin Exp Med. 7:108–114. 2014.PubMed/NCBI
|
|
11
|
Liu Y, Cai H, Liu J, Fan H, Wang Z, Wang
Q, Shao M, Sun X, Diao J, Liu Y, et al: A miR-151 binding site
polymorphism in the 3′-untranslated region of the cyclin E1 gene
associated with nasopharyngeal carcinoma. Biochem Biophys Res
Commun. 432:660–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Q, Fan H, Liu Y, Yin Z, Cai H, Liu J,
Wang Z, Shao M, Sun X, Diao J, et al: Curcumin enhances the
radiosensitivity in nasopharyngeal carcinoma cells involving the
reversal of differentially expressed long non-coding RNAs. Int J
Oncol. 44:858–864. 2014.PubMed/NCBI
|
|
13
|
Djuranovic S, Nahvi A and Green R: A
parsimonious model for gene regulation by miRNAs. Science.
331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang B, Jing C, Wang J, Guo X, Chen Y, Xu
R, Peng L, Liu J and Li L: Identification of microRNAs associated
with lymphangiogenesis in human gastric cancer. Clin Transl Oncol.
16:374–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang T, Sun Q, Liu T, Chen J, Du S, Ren
C, Liao G and Yuan Y: MiR-451 increases radiosensitivity of
nasopharyngeal carcinoma cells by targeting ras-related protein 14
(RAB14). Tumour Biol. 35:12593–12599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nygren MK, Tekle C, Ingebrigtsen VA,
Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T,
Alsner J, et al: Identifying microRNAs regulating B7-H3 in breast
cancer: The clinical impact of microRNA-29c. Br J Cancer.
110:2072–2080. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ito T, Sato F, Kan T, Cheng Y, David S,
Agarwal R, Paun BC, Jin Z, Olaru AV, Hamilton JP, et al: Polo-like
kinase 1 regulates cell proliferation and is targeted by miR-593*
in esophageal cancer. Int J Cancer. 129:2134–2146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Zheng L, Huang J, Gao F, Lin X,
He L, Li D, Li Z, Ding Y and Chen L: MiR-124 Radiosensitizes human
colorectal cancer cells by targeting PRRX1. PLoS One. 9:e939172014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-∆∆CT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yaromina A, Krause M, Thames H, Rosner A,
Krause M, Hessel F, Grenman R, Zips D and Baumann M: Pre-treatment
number of clonogenic cells and their radiosensitivity are major
determinants of local tumour control after fractionated
irradiation. Radiother Oncol. 83:304–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu ZX, Ma XQ, Yang LF, Wang ZL, Zeng L, Li
ZJ, Li XN, Tang M, Yi W, Gong JP, et al: DNAzymes targeted to
EBV-encoded latent membrane protein-1 induce apoptosis and enhance
radiosensitivity in nasopharyngeal carcinoma. Cancer Lett.
265:226–238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pearce AG, Segura TM, Rintala AC,
Rintala-Maki ND and Lee H: The generation and characterization of a
radiation-resistant model system to study radioresistance in human
breast cancer cells. Radiat Res. 156:739–750. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baldwin AS: Control of oncogenesis and
cancer therapy resistance by the transcription factor NF-kappaB. J
Clin Invest. 107:241–246. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kunnumakkara AB, Diagaradjane P, Guha S,
Deorukhkar A, Shentu S, Aggarwal BB and Krishnan S: Curcumin
sensitizes human colorectal cancer xenografts in nude mice to
gamma-radiation by targeting nuclear factor-kappaB-regulated gene
products. Clin Cancer Res. 14:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Javvadi P, Segan AT, Tuttle SW and
Koumenis C: The chemopreventive agent curcumin is a potent
radiosensitizer of human cervical tumor cells via increased
reactive oxygen species production and over activation of the
mitogen-activated protein kinase pathway. Mol Pharmacol.
73:1491–1501. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Narang H and Krishna M: Inhibition of
radiation induced nitration by curcumin and nicotinamide in mouse
macrophages. Mol Cell Biochem. 276:7–13. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hannoun-Levi JM, Chand-Fouche ME, Dejean C
and Courdi A: Dose gradient impact on equivalent dose at 2 Gy for
high dose rate interstitial brachytherapy. J Contemp Brachytherapy.
4:14–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Montazami N, Aghapour M, Farajnia S and
Baradaran B: New insights into the mechanisms of multidrug
resistance in cancers. Cell Mol Biol (Noisy-le-grand). 61:70–80.
2015.PubMed/NCBI
|
|
29
|
Maier P, Herskind C, Fleckenstein K, Spier
I, Laufs S, Zeller WJ, Fruehauf S and Wenz F: MDR1 gene transfer
using a lentiviral SIN vector confers radioprotection to human
CD34+ hematopoietic progenitor cells. Radiat Res. 169:301–310.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oh JS, Kim JJ, Byun JY and Kim IA:
Lin28-let7 modulates radiosensitivity of human cancer cells with
activation of K-Ras. Int J Radiat Oncol Biol Phys. 76:5–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
van Jaarsveld MT, Wouters MD, Boersma AW,
Smid M, van Ijcken WF, Mathijssen RH, Hoeijmakers JH, Martens JW,
van Laere S, Wiemer EA and Pothof J: DNA damage responsive
microRNAs misexpressed in human cancer modulate therapy
sensitivity. Mol Oncol. 8:458–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun Q, Liu T, Zhang T, Du S, Xie GX, Lin
X, Chen L and Yuan Y: MiR-101 sensitizes human nasopharyngeal
carcinoma cells to radiation by targeting stathmin 1. Mol Med Rep.
11:3330–3336. 2015.PubMed/NCBI
|
|
33
|
Mansour WY, Bogdanova NV, Kasten-Pisula U,
Rieckmann T, Köcher S, Borgmann K, Baumann M, Krause M, Petersen C,
Hu H, et al: Aberrant overexpression of miR-421 downregulates ATM
and leads to a pronounced DSB repair defect and clinical
hypersensitivity in SKX squamous cell carcinoma. Radiother Oncol.
106:147–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ke G, Liang L, Yang JM, Huang X, Han D,
Huang S, Zhao Y, Zha R, He X and Wu X: MiR-181a confers resistance
of cervical cancer to radiation therapy through targeting the
pro-apoptotic PRKCD gene. Oncogene. 32:3019–3027. 2013. View Article : Google Scholar : PubMed/NCBI
|
